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Many lines of evidence suggest that the Parkinson’s disease (PD)-related protein -synuclein (-SYN) can propagate from cell to cell in
a prion-like manner. However, the cellular mechanisms behind the spreading remain elusive. Here, we show that human astrocytes
derived from embryonic stem cells actively transfer aggregated -SYN to nearby astrocytes via direct contact and tunneling nanotubes
(TNTs). Failure in the astrocytes’ lysosomal digestion of excess -SYN oligomers results in -SYN deposits in the trans-Golgi network
followed by endoplasmic reticulum swelling and mitochondrial disturbances. The stressed astrocytes respond by conspicuously sending
out TNTs, enabling intercellular transfer of -SYN to healthy astrocytes, which in return deliver mitochondria, indicating a TNT-
mediated rescue mechanism. Using a pharmacological approach to inhibit TNT formation, we abolished the transfer of both -SYN and
mitochondria. Together, our results highlight the role of astrocytes in -SYN cell-to-cell transfer, identifying possible pathophysiological
events in the PD brain that could be of therapeutic relevance.
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Introduction
Cellular inclusions in the brain, often referred to as Lewy bodies
and Lewy neurites, are a pathological hallmark for Parkinson’s
disease (PD) and several other neurodegenerative disorders, in-
cluding dementia with Lewy bodies and multiple system atrophy
(Spillantini et al., 1998). The inclusions predominantly consist of
insoluble fibrillary forms of the -synuclein (-SYN) protein
(Spillantini et al., 1997), but smaller soluble aggregates are also
present in the diseased brain. These aggregates, referred to as
-SYN oligomers, are particularly neurotoxic (Danzer et al.,
2007; Chinta et al., 2010; Winner et al., 2011; Luth et al., 2014;
Ogen-Shtern et al., 2016). Although -SYN deposits are primar-
ily found in neurons, they also appear frequently in glial cells atReceived April 11, 2017; revised Sept. 20, 2017; accepted Oct. 11, 2017.
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Significance Statement
Astrocytes are the major cell type in the brain, yet their role in Parkinson’s disease progression remains elusive. Here, we show that
human astrocytes actively transfer aggregated -synuclein (-SYN) to healthy astrocytes via direct contact and tunneling nano-
tubes (TNTs), rather than degrade it. The astrocytes engulf large amounts of oligomeric -SYN that are subsequently stored in the
trans-Golgi network region. The accumulation of -SYN in the astrocytes affects their lysosomal machinery and induces mito-
chondrial damage. The stressed astrocytes respond by sending out TNTs, enabling intercellular transfer of -SYN to healthy
astrocytes. Our findings highlight an unexpected role of astrocytes in the propagation of -SYN pathology via TNTs, revealing
astrocytes as a potential target for therapeutic intervention.
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advanced disease stages (Tu et al., 1998; Wakabayashi et al., 2000;
Terada et al., 2003; Croisier and Graeber, 2006; Braak et al.,
2007). However, the consequences of astrocytic -SYN inclu-
sions for progression and spreading of PD pathology remain
unknown.
Being the most abundant glial cell type in the nervous system,
astrocytes play an important role in maintaining brain homeostasis
(Sofroniew and Vinters, 2010). The complex role of astrocytes in the
pathological brain is largely dependent on their release and uptake of
substances from the microenvironment that they share with the
neurons (Sofroniew and Vinters, 2010). For example, astrocytes
confer neuroprotection by removing excessive extracellular glu-
tamate, potassium, and calcium, whereas they produce cytokines
and chemokines that could be harmful to neurons if released
chronically (Rappold and Tieu, 2010; Sofroniew and Vinters,
2010).
Reactive astrocytes effectively engulf dead cells, synapses, and
protein aggregates of amyloid  (A) and -SYN (Chang et al.,
2000; Magnus et al., 2002; Sokolowski et al., 2011; Lööv et al.,
2012; Chung et al., 2013; Fellner et al., 2013; Jones et al., 2013;
Söllvander et al., 2016). Moreover, experimental evidence from
in vitro and in vivo studies indicates that -SYN can transfer from
cell to cell and thereby contribute to disease progression (Kor-
dower et al., 2008; Li et al., 2008; Desplats et al., 2009; Lee et al.,
2010; Danzer et al., 2011; Hansen et al., 2011). Several transfer
mechanisms have been suggested, including exocytosis/endocy-
tosis, extracellular vesicle secretion, and prion-like spreading, but
many questions remain regarding -SYN spreading and the in-
volvement of various cell types, notably astrocytes (Gousset et al.,
2009; Jang et al., 2010; Emmanouilidou et al., 2011).
Tunneling nanotubes (TNTs) are thin protrusions that allow
direct physical connections of the plasma membranes between
remote cells. The existence of TNTs was described for the first
time in 2004 (Rustom et al., 2004). Subsequently, TNTs have
been found in numerous cell types, including neurons and glial
cells (Zhu et al., 2005; Wang et al., 2012). Their primary function
is to transfer cellular components such as organelles, proteins,
genetic materials, ions, and small molecules between cells over
long distances (Kimura et al., 2013). However, TNTs have also
been suggested to be important in pathological conditions by
facilitating the intercellular spreading of viruses and pathogenic
proteins (Rustom et al., 2004). The smallest TNTs (100 nm in
diameter) only contain F-actin, whereas thicker TNTs (100 nm
in diameter) are composed of both F-actin and microtubules and
allow cell-to-cell transfer of larger compartments such as organ-
elles (Wang et al., 2011; Sisakhtnezhad and Khosravi, 2015).
Therefore, TNT formation can effectively be inhibited by F-actin
depolymerization drugs such as latrunculin B (Bukoreshtliev et
al., 2009).
Knowledge about the cellular mechanisms behind the initia-
tion and propagation of PD is still very limited. Here, we show
that human astrocytes engulf large amounts of -SYN oligomers
that are subsequently stored in the trans-Golgi region. The accu-
mulation of -SYN in the astrocytes affects their phagosomal–
lysosomal machinery and induces mitochondrial damage. As a
consequence of these stress reactions, the -SYN-containing as-
trocytes protrude TNTs, which mediate transfer of -SYN aggre-
gates and mitochondria between neighboring cells. Together, our
results highlight an unexpected role of astrocytes in the progres-
sion of -SYN pathology.
Materials and Methods
-SYN oligomer generation and labeling
Recombinant -SYN (140 M) was produced as described previously
(Näsström et al., 2011). Monomeric -SYN was incubated with 4-hydroxy-
nonenal (HNE) (Cayman Chemicals) in a HNE: -SYN ratio of 30:1 at
37°C for 72 h. SEC-HPLC was performed on a Superose 6 PC 3.2/30
column (GE Healthcare) and revealed a near complete conversion
from monomers to oligomers (Fig. 1-1 B, available at https://doi.org/10.
1523/JNEUROSCI.0983-17.2017.f1-1). As an eluent, 20 mM Tris and
0.15 M NaCl, pH 7.4, was used at a flow rate of 50 l/min. The -SYN
oligomers were labeled with the Cy3 AM Antibody Labeling Kit (GE
Healthcare, PA33000), the Atto 488 protein labeling kit (Sigma-Aldrich)
or pHrodo (Invitrogen, P36600). The pHrodo dye reacts with amine
groups on the cell surface and is nonfluorescent at neutral pH, but
emits red light at an increasing intensity as the pH is lowered. For all
labeling, the protocols provided with the dye kits were followed and
unbound excess Cy3, Atto 488, or pHrodo were removed by filtration
in a Zeba spin desalting column (Thermo Scientific) according to the
manufacturer’s instructions.
Culture of human embryonic stem cell (ESC)-derived astrocytes
Human ESC-derived astrocytes were generated as described previously
(Holmqvist et al., 2015; Stem Cell Research). The cells were cultured in
Advanced DMEM/F12 (Thermo Fisher Scientific, 12634-010) supplied
with 1% FBS (Thermo Fisher Scientific, 10082-147), 1% penicillin/
streptavidin (Thermo Fisher Scientific, 15140-122), 2 g/ml heparin
(Sigma-Aldrich, H4784), 10% B27 supplement (Thermo Fisher Scien-
tific, 17504-044), 1% nonessential amino acids (Merck Millipore,
TMS001-C), and 1% L-glutamine (Thermo Fisher Scientific, 25030-
024). Cells were passaged using Trypsin-EDTA (Life Technologies).
Cells from 90 to 120 d in vitro (DIV) were used in the study. For experi-
ments, the astrocytes were seeded at a concentration of 1500 cells/cm 2,
resulting in a 20 –30% confluence. TUNEL analysis showed that apopto-
tic cell death in the culture was 3% (Fig. 3-1 B, C, available at https://
doi.org/10.1523/JNEUROSCI.1005-17.2017.f3-1).
Alpha-synuclein exposure
Astrocyte cultures were exposed to 0.5 M -SYN oligomers or -SYN
monomers for 24 h. This concentration was chosen based on our previ-
ous investigations of neuronal– glial cocultures, demonstrating that
astrocytes rapidly internalized particularly large amounts of -SYN oli-
gomers (Lindström et al., 2017). After exposure, the cells were thor-
oughly washed in medium two times and continuously cultured in
medium without oligomers or monomers. At 0, 3, and 6 d after exposure,
the cells were fixed for further analyses. Parallel control cultures were left
untreated and fixed at the same time points.
Time-lapse microscopy
Cells were recorded using time-lapse microscopy (Nikon Biostation IM
Cell Recorder). Images were taken at 20, 40, or 80  magnifications
every 5 or 10 min. The duration of the experiment was 24 h during the
-SYN oligomer exposure or 72 h after the 24 h -SYN oligomer expo-
sure (and wash).
Western blot analysis
At 0, 3, and 6 d after -SYN oligomer and monomer exposure, cells were
lysed in lysis buffer containing 20 mM Tris, pH 7.5, 0.5% Triton X-100,
0.5% deoxycholic acid, 150 mM NaCl, 10 mM EDTA, 30 mM NaPyroP,
500 M sodium orthovanadate, and 1 protease inhibitor (Thermo
Fisher Scientific, 78430) on ice for 30 min before centrifugation for
30 min at 4°C 12,000  g. The supernatants were transferred to new tubes
and the pellets and lysates were kept in 70°C until analysis. To study
autophagic flux, control cells and -SYN oligomer-exposed cells were
treated with bafilomycin (500 nM, Millipore) at 24 h  6 d for 6 h before
lysis. Protein concentration was measured using the BCA protein assay
kit (Thermo Fisher Scientific, 23225) according to the manufacturer’s
protocol.
A total volume of 40 l of each sample, containing 20 g of protein,
1 Bolt Sample Reducing agent (Thermo Fisher Scientific), and 1
NuPAGE LDS sample buffer (Thermo Fisher Scientific), was loaded to a
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4 –12% NuPAGE Bis-Tris gel (Thermo Fisher Scientific). Chameleon kit
700 and 800 prestandard protein ladders (LICOR) were mixed and added
to the gel. The gel was run at 200 V for 30 min in Bolt MES SDS Running
buffer (1, Thermo Fisher Scientific). The PVDF membrane was acti-
vated in methanol for 5 min before transfer at 22 V for 1 h in MES transfer
buffer (1) supplied with 10% methanol, 0,1% Bolt antioxidants
(Thermo Fisher Scientific) and 0.01% SDS. For -SYN monomer and
oligomer detection, membranes were fixed with 0.4% PFA for 30 min
and washed with PBS 3 5 min before blocking in 5% BSA in TBS for 1 h
at room temperature. The membranes were then incubated with primary
antibodies overnight at 4°C. The primary antibodies used were as follows:
LAMP-1 (1:1000, Abcam, ab24170), LC3B (1:500, Novus Biologicals,
NB100-2220SS), p62 (1:500, Novus Biologicals, NBP1-48320SS),
GAPDH (Novus Biologicals, NB300-221), and FL-140 (1:1000, Santa
Cruz Biotechnology). The following day, the membranes were washed
in 0,1% Tween in TBS (TBS-T) 3 10 min before incubation with
HRP-coupled secondary antibody (1:20,000, Pierce) for 1 h at room
temperature. After 3 10 min washes with TBS-T, the membranes were
incubated with the ECL prime Western blotting detection reagents (1:1
mixture of reagent A and B, GE Healthcare) and the signal was measured
using the ChemiDoc XRS machine (Bio-Rad).
To detect -SYN oligomers in the pellet, samples were resuspended in
1% SDS and 1 protease inhibitor in TBS. The samples were boiled in
95°C for 5 min before sonication for 30 s with 1 s pulse on/off and an
amplitude of 20%. The samples were treated as the other samples before
loading to the gel.
Luminescent ATP detection kit
Cells were grown in 24-well plates (5,000 cells/cm 2 cells per well) and
exposed to -SYN oligomers as described previously. The total ATP
levels were analyzed at 24 h  6 d with the Luciferase-Based Luminescent
ATP Detection Assay Kit (Abcam, ab113849) according to the manufac-
turer’s protocol. As a positive control, cells were incubated with a 5 M
concentration of the mitochondrial electron transport inhibitor antimy-
cin A (Sigma-Aldrich, A8674) for 21 h before measurement. Lumines-
cence was measured with an Infinite M1000 plate reader (Tecan). The
assay was performed in a biological replicate of n  6; that is, from 6
different batches of cells. Luminescence values are presented as the rela-
tive change compared with untreated control cultures.
Coculture experiments with RFP/GFAP-expressing astrocytes
Different coculture systems were used to study cell-to-cell transfer of
-SYN oligomers and mitochondria. Unlabeled astrocytes and astrocytes
expressing tagged-RFP (tRFP) under the GFAPABC1D promoter (Holmqvist
et al., 2015) were used as either acceptor or donor cells. The different com-
binations are described below.
-SYN transfer to unexposed, tRFP acceptor astrocytes. Unlabeled astro-
cytes were treated with Atto 488-labeled -SYN oligomers for 24 h fol-
lowed by washes. At 24 h  2 d, the exposed astrocytes (donor cells) were
trypsinized and added to the unexposed tRFP astrocytes (acceptor cells).
After 24 h of coculture, the cells were fixed. Actin polymerization was
inhibited by addition of latrunculin B (1 M, Sigma-Aldrich) 3 h after the
coculture was started.
Mitochondria transfer from -SYN oligomer-exposed astrocytes to
unexposed, tRFP acceptor astrocytes. Unlabeled astrocytes were treated
with unlabeled -SYN oligomers for 24 h followed by washes. At 24 h 
1 d, the -SYN oligomer-exposed astrocytes were transfected with cell-
Light mitochondria-GFP (Mitotracker, Thermo Fisher Scientific) at 20
particles per cell (PPC) (donor cells). Unexposed, tRFP astrocytes (ac-
ceptor cells) were added to the donor cells at 24 h  2 d. After 24 h of
coculture, the cells were fixed. Actin polymerization was inhibited using
latrunculin B (1 M) 3 h after the coculture was started.
Mitochondria transfer from unexposed tRFP astrocytes to -SYN
oligomer-exposed acceptor astrocytes. Unlabeled astrocytes were treated
with unlabeled -SYN oligomers for 24 h followed by washes. At 24 h 
1 d unexposed, tRFP astrocytes were transfected with Miotracker (20
PPC, donor cells). The tRFP astrocytes (donor cells) were added to the
-SYN oligomer-exposed astrocytes at 24 h  2 d (acceptor cells), fol-
lowed by 24 h of coculture and fixation. Actin polymerization was inhib-
ited using latrunculin B (1 M) 3 h after the coculture was started.
Mitochondrial transfer was also studied in parallel cocultures in which
neither the acceptor cells nor the donor cells were treated with -SYN
oligomers.
Immunocytochemistry
Cells were fixed in 4% PFA in PBS, washed, and blocked with 5% normal
goat serum (NGS) and 0.1% Triton in PBS for 30 min in room temper-
ature. Primary antibodies were diluted in 0.5% NGS and 0.1% Triton in
PBS and added to the cells for 2 h in room temperature. Thereafter, cells
were washed 3 with PBS before incubation with secondary antibodies
and dyes for 45 min at 37°C. After additional washes, cells were mounted
with Vectashield Hard Set Mounting medium with DAPI or without
DAPI (BioNordika) and analyzed using the fluorescence microscope
Observer Z1 Zeiss. Confocal images were taken using Zeiss LSM700 and
LSM 710 and 3D images were performed using the IMARIS 8.2 program.
The following primary antibodies were used: anti-nestin (1:400, Milli-
pore, ABD69), anti-S100B (1:200, Sigma-Aldrich, S2532), anti-vimentin
(1:200, Abcam, ab5733), anti-LAMP1 (1:200, Abcam, ab24170), anti-
TGN46 (1:100, Abcam, ab50595), anti-COXIV (mouse monoclonal,
1:100, Abcam, ab14744), anti-COXIV (rabbit polyclonal, 1:100, Abcam,
ab16056), anti-DRP-1 (1:200, Abcam, ab56788), anti-LC3B (1:200, Ab-
cam, ab51520), anti-Golgi complex antibody (1:200, Abcam, ab103439),
and anti-calnexin (1:200, Santa Cruz Biotechnology, sc11397). The fol-
lowing secondary antibodies and dyes were used: Alexa Fluor 488 goat
anti rabbit/mouse (1:200, Abcam), Alexa Fluor Cy3 goat anti rabbit/
mouse (1:200, Abcam), and Alexa Fluor 488 phalloidin (Sigma-Aldrich).
To stain the plasma membrane, fixed cells were washed 3 with HBSS
(Life Technologies) before incubation with wheat germ agglutinin
(WGA), Alexa Fluor 350 conjugate (1:200, Life Technologies) for 10 min.
Astrocytic apoptosis was measured using terminal (TdT)-mediated
dUTP-biotin reaction mixture (TUNEL, Roche Biochemicals) according
to the manufacturer’s instructions. Mitochondria were labeled with cell-
Light mitochondria-GFP BacMam 2.0 (Thermo Fisher Scientific) and
LC3B  vesicles were labeled with the Premo Autophagy Tandem Sensor
RFP-GFP-LC3B Kit. As a control to the Autophagy Tandem Sensor RFP-
GFP-LC3B Kit, 90 M chlouroscin was added to the cells for 8 h before
fixation. The transfection reagents were mixed in the cell medium at 20
PPC and added to the cells for 24 h before fixation.
Transmission electron microscopy (TEM)
Astrocyte cultures were fixed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer (SCB), pH 7.4. The cell culture dishes were then rinsed
in 0.1 M SCB for 10 min and incubated in 1% OsO4 in 0.1 M SCB for 1 h.
Dehydration was performed with 70% ethanol for 30 min, 95% ethanol
for 30 min, and 99.7% ethanol for 1 h. The dishes were rinsed with plastic
(Agar 100 resin kit, Agar Scientific) and a new, thin layer of plastic was
added to the cells for 2– 4 h to permit evaporation of the alcohol. A
second plastic layer was poured on and left overnight before a thicker,
newly made plastic layer was added. The dishes were incubated at room
temperature for 1 h before polymerization in the oven (60°C) for 48 h.
The cells were studied in a Hitachi H-7100 TEM.
Quantifications and statistics
Intensity measurements of -SYN deposits. In total, 12 images per exper-
iment and time point were captured at days 0, 3, and 6 after -SYN
oligomer exposure. Zen 2012 software was used to analyze the intensity
and number of -SYN inclusions from four independent experiments.
The data were analyzed in GraphPad Prism 6.0 software using Kruskal–
Wallis statistical analysis.
Analysis of TUNEL assay. In total, 12 images per experiment and time
point were captured at days 0, 3, and 6 after -SYN oligomer exposure or
latrunculin B treatment and in parallel control cultures. Two indepen-
dent experiments were performed and the number of TUNEL  cells and
the total cell number were determined manually. The data were analyzed
in GraphPad Prism 6.0 using two-way ANOVA statistical analysis.
Intensity measurement of Western blot analysis. The LC3BII/I ratio,
normalized to GAPDH, and the p62 levels, normalized to GAPDH, were
measured in three independent experiments using Image Lab software.
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The data were analyzed in GraphPad Prism 6.0 using one-way ANOVA
statistical analysis.
Analysis of autophagic flux using LC3B tandem. To determine whether
the autolysosomes were affected by the -SYN treatment, astrocytes were
transfected with LC3B tandem where the LC3B protein is coupled to
RFP and pH-sensitive GFP. When the autophagosomes fuse with the
lysosomes, the pH-sensitive GFP will be degraded. Twenty cells from
each time point were analyzed. Cells with only RFP /GFP  vesicles and
cells with a mixture of RFP  and RFP /GFP  vesicles were counted
manually in four independent experiments and analyzed using one-way
ANOVA statistical analysis.
Morphology analysis of endoplasmic reticulum (ER) in TEM images.
Images were captured in close proximity to the nucleus with a magnifi-
cation of 20,500 and the ER width was measured using ImageJ soft-
ware. In total, the ER width from 14 -SYN oligomer-exposed astrocytes
and 13 untreated, control astrocytes were measured. The data were ana-
lyzed in GraphPad Prism 6.0 using Student’s t test statistical analysis.
Morphology analysis of mitochondria in TEM images. For measure-
ments of the effect of -SYN oligomers on mitochondrial fusion/fission,
the mitochondria were divided into two groups depending on their
length: normal mitochondria (1 m) and dense/fragmented mito-
chondria (1 m). Mitochondria within the two groups were quantified
in 14 -SYN oligomer-exposed astrocytes and in 12 untreated, control
astrocytes. The data were analyzed in GraphPad Prism 6.0 using two-way
ANOVA statistical analysis.
Morphology analysis of mitochondria in immunocytochemistry images.
COXIV  mitochondrial clumps were measured using ImageJ software
in 20 images per experiment and time point at days 0, 3, and 6 after
-SYN-Cy3 exposure and in parallel control cultures. Three indepen-
dent experiments were performed and the data were analyzed in Graph-
Pad Prism 6.0 using Kruskal–Wallis statistical analysis.
Quantification of TNTs. For analysis, TNTs were stained with phalloi-
din and WGA. The inclusion criterion for TNTs herein was protrusions
connecting two cells with a length of 5–100 m. In total, 20 images per
experiment and time point were captured at day 0, 3, and 6 cultures after
-SYN oligomer exposure and in parallel control cultures. Four indepen-
dent experiments were performed and the number of TNTs was deter-
mined manually and analyzed using ANOVA statistical analysis. Actin
polymerization was inhibited by the addition of latrunculin B 2 d after
the 24 h -SYN oligomer exposure. The cell cultures were fixed 1 d later
(at day 3 after the -SYN oligomer exposure). The effect of latrunculin B
on TNT formation was analyzed in 20 images per experiment in -SYN
oligomer-exposed astrocytes in the absence and presence of latrunculin
B. Four independent experiments were performed and the data were
analyzed using Student’s t test.
Quantifications of transfer in the cocultures. Mitochondria and
-SYN  acceptor cells in the absence and presence of latrunculin B were
counted in 16 images per experiment. Three independent experiments
were performed and the data were analyzed using Mann–Whitney statis-
tical analysis.
Results
-SYN oligomers accumulate in astrocytes after ingestion
Human ESC-derived astrocytes (Holmqvist et al., 2015) ex-
pressing the markers nestin, vimentin, S100, and GFAP (Fig.
1-1A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.
2017.f1-1) were exposed to, 0.5 M Cy3-labeled -SYN oligom-
ers (Fig. 1-1B, available at https://doi.org/10.1523/JNEUROSCI.
0983-17.2017.f1-1) for 24 h (see schematic outline in Fig. 1A).
Compared with S100 and nestin, the expression of GFAP was
rather low, but none of the astrocytes were completely GFAP.
Live-cell imaging starting instantly after exposure visualized up-
take of -SYN oligomers (starred in the figures) in the astrocytes
(Fig. 1-2A, available at https://doi.org/10.1523/JNEUROSCI.
0983-17.2017.f1-2). After engulfment (Fig. 1-2A, available at
https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-2, 11 h 25
min to 11 h 55 min), the astrocytes contracted and temporar-
ily rounded up as -SYN was transported to the region
around the nuclei (Fig. 1-2 A, available at https://doi.org/10.
1523/JNEUROSCI.0983-17.2017.f1-2, 19 h 05 min to 21 h 36
min), where it persisted throughout the time-lapse experiment.
Contraction after engulfment of large pathogens have been de-
scribed previously in other phagocytic cells (Evans et al., 1993).
Moreover, we confirmed the intracellular location of the engulfed
-SYN-Cy3 oligomers in the astrocytes by actin labeling and confo-
cal 3D imaging (Fig. 1B). To investigate whether the -SYN inclu-
sions were degraded by the human astrocytes, the cells were
thoroughly washed after the 24 h -SYN-Cy3 oligomer exposure
and cultured for an additional 3 or 6 d in -SYN-free medium
before fixation (see schematic outline in Fig. 1A). Interestingly,
we found that the ingested -SYN oligomers remained in the cells
throughout the experiment (Fig. 1-2B, available at https://doi.
org/10.1523/JNEUROSCI.0983-17.2017.f1-2). To verify this re-
sult, we performed Western blot analysis of total whole-cell ly-
sates and pellet fractions with antibodies directed to -SYN (Fig.
1-2C, available at https://doi.org/10.1523/JNEUROSCI. 0983-17.
2017.f1-2). The reason that we included analysis of the pellet
fractions was that we have noted previously that intracellular
deposits of amyloid- in astrocytes end up in the pellet fraction
due to their compact and large structure (Söllvander et al.,
2016). As expected, SDS treatment of the -SYN oligomers
resulted in dissociation into a wide range of high- and low-mole-
cular-weight -SYN species (Fig. 1-2C, available at https://doi.
org/10.1523/JNEUROSCI.0983-17.2017.f1-2; Näsström et al.,
2011). Interestingly, our data show that there was a reduction
in high-molecular-weight SYN species in the lysates over time,
but the high-molecular-weight SYN species in the pellet frac-
tion remained rather intact at all three time points, demonstrat-
ing that the -SYN oligomers were not effectively degraded by the
cells over the 6 d time period (Fig. 1-2C, available at https://doi.
org/10.1523/JNEUROSCI.0983-17.2017.f1-2). The immunos-
tainings showed that all astrocytes in the -SYN-exposed cultures
had -SYN deposits and we did not observe any obvious differ-
ence in uptake or accumulation of -SYN in cells with high versus
low GFAP expression. In contrast to the oligomers, monomeric
-SYN was degraded rapidly by the human astrocytes (Fig. 1-3,
A,B, available at https://doi.org/10.1523/JNEUROSCI.0983-17.
2017.f1-3).
Quantifications of the Cy3 signal at the different time points
after oligomer exposure (Fig. 1C) demonstrated that the total
area of the inclusions per astrocyte (Fig. 1D) and the number of
deposits per astrocyte (Fig. 1E) were stable over time and did not
change significantly from days 0 to 6, indicating minimal degra-
dation of the ingested aggregated -SYN during the 6 d time
period. However, the mean area per inclusion (Fig. 1F) and the
mean intensity per field (Fig. 1G) increased significantly over
time (p  0.001). These results could be explained by the fact that
the aggregates were brought closer together over the 6 d period
when the -SYN was relocated to the region around the cell nu-
clei. This is a phenomenon the we demonstrated previously after
astrocytic engulfment of amyloid- oligomers (Söllvander et al.,
2016).
Lysosomal machinery fails to degrade ingested -SYN
oligomers
To determine whether the internalized -SYN oligomers entered
the lysosomal pathway, we performed immunostaining with endo-
somal/lysosomal-associated membrane protein 1 (LAMP-1).
The stainings showed an increased perinuclear localization of
LAMP-1 at day 3 after exposure to -SYN oligomers compared
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Figure 1. Intracellular -SYN is stored rather than degraded. Human ESC-derived astrocytes (see Fig. 1-1 A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-1) were exposed to 0.5 M
Cy3-labeled-SYN oligomers (see Fig. 1-1 B, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-1) for 24 h, washed thoroughly, and cultured for an additional 0, 3, or 6 d in-SYN-free medium
before fixation (A). The intracellular location of the -SYN-Cy3 after ingestion (see Fig. 1-2 A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-2) was confirmed with confocal imaging (B).
Quantification of the -SYN-Cy3 signal at days 0, 3, and 6 (C and Fig. 1-2 B, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-2) reveled the total area of the -SYN deposits per astrocyte in
square millimeters (D), the number of-SYN deposits per astrocyte (E), the mean area of the deposits in square millimeters (F ), and the mean intensity of the intracellular-SYN-Cy3 per field (G). Western blot
analysisconfirmedthepresenceofhigh-molecular-weight-SYNspecies intheastrocytesatall threetimepoints(Fig.1-2C,availableathttps://doi.org/10.1523/JNEUROSCI.0983-17.2017.f1-2),demonstrating
that only minimal degradation of the ingested oligomeric -SYN occurred, whereas the monomeric -SYN was completely degraded during the 6 d time period (see Fig. 1-3A, B, available at https://doi.org/
10.1523/JNEUROSCI.0983-17.2017.f1-3).Scalebars:B,10m;C,20m.DataarepresentedasmeanSDfromfourindependentexperimentsandthelevelsofsignificanceweresetto*p0.05,**p0.01,
and ***p  0.001 (E–G).
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Figure 2. Ingested -SYN only temporarily colocalizes with the lysosomal protein LAMP-1. Representative images of LAMP-1 staining from -SYN oligomer-exposed astrocytes and control cells
showed a pronounced colocalization of LAMP-1 and -SYN at day 3 (24 h  3 d). At day 6 (24 h  6 d), the colocalization was lost, although the -SYN deposits were not degraded (A, Fig. 2-1,
available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f2-1, and Fig. 2-2, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f2-2). N, Nucleus. Confocal imaging demonstrated
clear colocalization of LAMP-1 and -SYN at day 3 (24 h  3 d) (B). A close-up of the white rectangle is shown in B. Western blot analysis revealed no differences in LAMP-1 protein expression
between the control and the -SYN oligomer-exposed astrocytes (C). Scale bars: A, 20 m; B, 10 m.
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Figure 3. Accumulation of -SYN oligomers induces TNT formation. F-actin labeling using phalloidin (A) and membrane staining using WGA (B) showed that TNTs were formed between the
astrocytes at 0, 3, and 6 d (24 h  0 d, 24 h  3 d, and 24 h  6 d) after -SYN oligomer exposure. Confocal 3D imaging (C and Fig. 3-1 A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.
2017.f3-1) and TEM analysis (D) confirmed the presence of TNTs. Quantification of the total number of TNTs in cultures treated with -SYN oligomers or in parallel control cultures showed that the
number of TNTs was increased significantly after -SYN oligomer exposure at all time points. Moreover, the number of TNTs increased over time in the -SYN oligomer-treated cultures (E).
Latruculin B treatment reduced the number of TNTs significantly (F ). Importantly, neither the high load of -SYN oligomers nor the treatment with latrunculin B at the concentration and exposure
time used induced any obvious toxicity or cell death, as indicated by TUNEL staining and the total cell number (Fig. 3-1 B, C, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f3-1).
Scale bars: A, B, 20 m; C, 5 m; D, 1 m. Data are presented as mean  SD from four independent experiments and the levels of significance were set to *p  0.05, **p  0.01, and ***p 
0.001 (E, F ).
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Figure 4. TNTs contribute to -SYN transmission. Time-lapse experiments of -SYN-Cy3 oligomer-exposed cultures showed that -SYN was transported between the astrocytes in
the culture via direct contact or via TNTs (see Fig. 4-1 A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f4-1). The different time points after -SYN oligomer exposure
are indicated. Direct transmission by membrane fusion of two astrocytes is shown in A. Close-ups of the cell-to-cell contact region (white rectangle) demonstrate transmission of an
-SYN aggregate (white star) from the top cell to the bottom cell (15 h 20 min to 15 h 30 m after 24 h of -SYN oligomer exposure) (A). The -SYN is then relocated toward the cell nuclei
(N). Transfer of -SYN-Cy3 via TNTs is shown in B. The TNT formation was rather quick and took 10 min (2 h 40 min to 2 h 50 min) (B). Close-up imaging (white rectangle) over the after
20 min demonstrated clear TNT-mediated transfer of aggregated -SYN (white arrowheads) (B). Confocal microscopy confirmed the presence of -SYN in (Figure legend continues.)
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with untreated control astrocytes (Fig. 2A and Fig. 2-1A,B, avail-
able at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f2-1).
Moreover, we confirmed that, at this time point (24 h  3 d),
most of the intracellular -SYN deposits colocalized with the
LAMP-1 vesicles (Fig. 2A,B). Notably, at day 6 (24 h  6 d), the
colocalization of LAMP-1 and -SYN was reduced dramatically,
although the -SYN inclusions had not been degraded (Fig. 2A
and Fig. 2-1, available at https://doi.org/10.1523/JNEUROSCI.
0983-17.2017.f2-1). LAMP-1 staining was also less perinuclear
at the latest time point without accomplishing the degradation
(Fig. 2A and Fig. 2-1 A, available at https://doi.org/10.1523/
JNEUROSCI.0983-17.2017.f2-1). Western blot analysis of
whole-cell lysates did not show any changes in total LAMP-1
expression between the control and -SYN-exposed astrocytes
(Fig. 2C), indicating that the endosomes/lysosomes were only
redistributed inside the cells. Next, we investigated whether the
engulfed -SYN oligomers came into contact with mature lyso-
somes. For this purpose, -SYN oligomers were prelabeled with
the pH-dependent dye pHrodo before being added to the astro-
cytes. The pHrodo dye is only initiated to fluoresce at low pH
such as that inside acidic lysosomes. We found pHrodo staining
at all the time points studied (24 h  0 d, 24 h  3 d, and 24 h  6 d),
indicating that at least some of the ingested oligomers were trans-
ported to acidic lysosomes (Fig. 2-2, available at https://doi.org/
10.1523/JNEUROSCI.0983-17.2017.f2-2). However, the pHrodo
signal did not decline over time. Instead, the fraction of intra-
cellular -SYN that was pHrodo labeled accumulated further
and formed deposits/inclusions (24 h  6 d) in the perinuclear
region, confirming severe failure of the lysosomal degrada-
tion. Therefore, the accumulation of pHrodo-labeled -SYN
was similar to the accumulation of Cy3-labeled -SYN. These
results show that the engulfed oligomeric -SYN was trans-
ported to lysosomal compartments, but the astrocytes were
incapable of degrading the -SYN oligomers by the lysosomal
machinery.
Intracellular accumulation of -SYN induces TNT formation
Cell-to-cell contacts via, for example, TNTs could facilitate inter-
cellular spreading of pathogenic proteins and organelles. To in-
vestigate whether the high load of intracellular -SYN deposits
affected the formation of TNTs between the astrocytes in the culture,
we stained the cellular cytoskeleton with the actin-binding dye
phalloidin (Fig. 3A) and the plasma membrane with WGA (Fig.
3B). We found that TNTs were frequently formed between the
astrocytes at 24 h  0 d, 24 h  3 d, and 24 h  6 d (hereafter
referred to as days 0, 3, and 6; Fig. 3 A, B). Analysis with con-
focal microscopy (Fig. 3C and Fig. 3-1 A, available at https://
doi.org/10.1523/JNEUROSCI.0983-17.2017.f3-1) and TEM (Fig.
3D) further confirmed the presence of TNTs. Quantification of
the total number of TNTs in cultures treated with -SYN oligom-
ers and in untreated control cultures showed that the -SYN
oligomer exposure clearly induced TNT formation because there
were significantly more TNTs in the -SYN oligomer-exposed
cultures (Fig. 3E). Moreover, the number of TNTs increased over
time (from 0 –3 d and from 0 – 6 d, p  0.001) after the 24 h of
-SYN oligomer exposure. Inhibition of actin polymerization by
the addition of latrunculin B reduced the number of TNTs in the
astrocyte culture significantly (Fig. 3F, p  0.001). Importantly,
neither the high load of -SYN oligomers nor the treatment with
latrunculin B at the concentration and exposure time used in-
duced any obvious toxicity or cells death, as indicated by TUNEL
staining and the total cell number (Fig. 3-1B,C, available at
https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f3-1).
TNTs contribute to -SYN transmission
Time-lapse experiments with Cy3-labeled -SYN oligomer-
exposed cultures demonstrated that -SYN aggregates of differ-
ent sizes (up to 5 m in diameter) could transfer between the
astrocytes in the culture (Fig. 4A,B and Fig. 4-1A, available
at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f4-1, and
Movies 1, 2, and 3). Direct transfer occurred between astrocytes
that were in close contact (Fig. 4A and Movie 1, second transfer).
Interestingly, we also noticed frequent transfer of -SYN-Cy3
aggregates via thin cell protrusions, which resembled TNTs (Fig.
4-1A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.
2017.f4-1, and Movie 1, first transfer). Accordingly, time-lapse
recordings also revealed transfer of -SYN-Cy3 between the
astrocytes via newly formed TNTs (Fig. 4B and Movies 2 and
3). Our time lapse-experiments indicated that very large in-
clusions of -SYN were transported via direct cell contact,
whereas smaller aggregates were easily transported via TNTs.
Using confocal microscopy, we confirmed the presence of
-SYN-Cy3 within actin-labeled TNTs (Fig. 4C and Fig. 4-1B,
available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.
f4-1). Moreover, cocultures of unlabeled astrocytes exposed to
-SYN oligomers and untreated astrocytes expressing tRFP un-
der the GFAPABC1D promotor (Holmqvist et al., 2015; Fig. 4D
and Fig. 4-2, available at https://doi.org/10.1523/JNEUROSCI.
0983-17.2017.f4-2) verified that -SYN-containing astrocytes
4
(Figure legend continued.) actin-labeled TNTs (C and Fig. 4-1B, available at https://doi.org/10.
1523/JNEUROSCI.0983-17.2017.f4-1), close-up of the white rectangles are shown in C and C
(white arrowheads indicate -SYN). Cocultures of unlabeled astrocytes exposed to Atto 488-
labeled -SYN oligomers and untreated GFAP::tRFP astrocytes (D and Fig. 4-2, available at
https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f4-2) demonstrated transfer of -SYN to
unaffected astrocytes via direct transfer (E) and TNTs (F). Close-ups of the cell-to-cell direct
contact region and TNTs (white rectangles) are shown in E and F, respectively (white arrow-
heads in F indicate -SYN). Latruculin B treatment reduced the percentage of -SYN  ac-
ceptor cells significantly (G). Scale bars: A–C, 10 m; E, F, 20 m. Data are presented as
mean  SEM from three independent experiments and the levels of significance were set to
*p  0.05, **p  0.01, and ***p  0.001 (G).
Movie 1. Time-lapse movie demonstrating that -SYN-Cy3 (red,
indicated with yellow arrow) are transferred from one astrocyte to an-
other via thin, TNT-like cell protrusions (first transfer) and by close,
membrane-to-membrane contact (second transfer).
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transferred -SYN to unaffected astrocytes via direct cell contact
(Fig. 4E) and via TNTs (Fig. 4F). The -SYN TNT-mediated
transmission was reduced significantly after pharmacological in-
hibition of actin polymerization using latrunculin B (Fig. 4G, p 
0.001). However, we cannot exclude that other transfer mecha-
nisms are also affected by the latrunculin B treatment. Altogether,
these data clearly demonstrate that astrocytic transfer of -SYN
occurs via TNTs in vitro and that pharmacological inhibition of
actin polymerization prevents -SYN transfer.
Storage of -SYN results in ER swelling and impaired
mitochondrial dynamics
Immunocytochemistry followed by confocal microscopy dem-
onstrated that the -SYN-Cy3 inclusions were situated in the
region of the trans-Golgi network (TGN) (Fig. 5A and Fig. 5-1A,
available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.
f5-1), but immunostaining with an anti-Golgi complex antibody
indicated that the accumulation did not result in TGN fragmen-
tation (Fig. 5B). However, from TEM analysis, it was obvious that
the -SYN accumulation resulted in severe defects in other cel-
lular organelles. Six days after -SYN oligomer exposure, the
astrocytes displayed the typical appearance of ER swelling, with a
pronounced increased volume of the ER lumen resembling a
vesicular appearance (Fig. 5C). Quantification of the ER width in
-SYN oligomer-exposed cultures and untreated control cul-
tures revealed that the -SYN treatment increased the ER width
significantly (p  0.001; Fig. 5D). Furthermore, we performed
immunostainings using specific antibodies to the ER-marker cal-
nexin. The results from the immunostainings showed that
there was a clearly higher expression of calnexin in the peri-
nuclear region of -SYN oligomers exposed astrocytes com-
pared with control astrocytes (Fig. 5E and Fig. 5-1B, available at
https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f5-1).
Moreover, -SYN oligomer-exposed cultures displayed al-
tered mitochondrial morphology, with an elevated number of
small and dense mitochondria (Fig. 6A). To be able to quantify
the effect on mitochondrial fusion/fission, we divided the mito-
chondria into two groups depending on their length and their
dense/fragmented morphologies (the normal mitochondria
were 1 m, whereas small/dense mitochondria were 1 m).
Quantification of the number of mitochondria in the two groups
showed that -SYN oligomer exposure increased the percentage
of small and dense mitochondria significantly (p  0.001) and
decreased the percentage of normal mitochondria (p  0.001; Fig.
6B). Immunostaining with the mitochondrial marker COXIV dem-
onstrated pathological clusters of mitochondria in the astrocytes,
further verifying the disrupted mitochondrial dynamics (Fig. 6C
and Fig. 6-1A, available at https://doi.org/10.1523/JNEUROSCI.
0983-17.2017.f6-1). Quantification of the total area of the
COXIV regions in astrocytes at day 6 demonstrated that the
presence of mitochondrial clusters increased significantly after
-SYN oligomer exposure (Fig. 6D). Double staining using spe-
cific antibodies to COXIV and DRP-1 followed by confocal im-
aging revealed an organized pattern of mitochondria and the
fission-regulating protein 0 and 3 d after -SYN oligomer expo-
sure, preceding the excessive amount of fragmented mitochon-
dria at day 6 (Fig. 6E,E	 and Fig. 6-1B, available at https://doi.
org/10.1523/JNEUROSCI.0983-17.2017.f6-1). These results in-
dicate that the mitochondrial clusters observed in Figure 6, C and
D, may be due, at least in part, to increased mitochondrial frag-
mentation. Interestingly, ATP measurement showed only a very
slight decrease (7%) in ATP levels after -SYN oligomer treat-
ment. In control cultures treated with the electron transport in-
hibitor antimycin A, there was also a very modest decrease in ATP
levels (13%) compared with untreated cultures (Fig. 6F). These
results, together with the low apoptotic frequency after -SYN
oligomer exposure observed with the TUNEL assays (Fig. 3-1B,
available at https://doi.org/10.1523/JNEUROSCI.0983-17. 2017.
f3-1), indicate that the astrocytes somehow are able to compen-
sate for the substantial mitochondrial damage.
Movie 2. Time-lapse movie demonstrating the formation of TNTs
between two astrocytes (indicated with yellow arrow).
Movie 3. Close-up of Movie 2 demonstrating transfer of -SYN-Cy3
(red, indicated with yellow arrow) from one astrocyte to another via the
newly formed TNT.
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Accumulation of -SYN affects the
autophagosomal machinery
Normally, defected mitochondria and protein aggregates are
degraded and removed from the cell by autophagy. When au-
tophagy is induced, the autophagosome is formed by conjugation
of cytosolic LC3B I (17 kDa) to phosphotidylethanolamine,
forming LC3BII (15 kDa), which is recruited to the autophago-
somal membrane by p62 (Katsuragi et al., 2015). The autopha-
gosome then fuses with the lysosome to form the autolysosome in
which the low pH will facilitate degradation of the material. Dur-
ing the fusion with the lysosomes, the low pH also degrades the
LC3BII and p62 proteins. To investigate whether the increased
number of fragmented mitochondria after -SYN exposure was
due to ineffective mitophagy, we next examined various steps of
the autophagy pathway, including formation of LC3B puncta,
LC3BII/I ratio, p62 expression, and autophagosomal turnover.
Because cytoplasmic LC3 is processed and recruited to the au-
tophagosomal membranes, it is possible to identify cells under-
Figure 5. Intracellular storage of -SYN in the TGN region causes ER swelling. Confocal microscopy imaging showed that -SYN-Cy3 inclusions localized to the region of the TGN46  TGN over
time (A and Fig. 5-1A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f5-1). Immunostainings with specific anti-Golgi complex antibodies demonstrated that the accumulation of
ingested -SYN oligomers in the TGN region did not induce Golgi fragmentation (B). TEM analysis of astrocytes 6 d after -SYN oligomer exposure (24 h  6 d) indicated that the -SYN storage
induced ER swelling (C) (white dotted lines indicate ER). Quantification of the ER width confirmed the induced ER swelling in oligomer-exposed astrocytes (D). Representative images from
immunostainings with the anti-calnexin antibody showed a higher expression of calnexin in the perinuclear region of -SYN oligomer-exposed astrocytes compared with control (E and Fig. 5-1B,
available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f5-1). Scale bars: A, 10 m; B, 20 m; C, 500 nm; E, 20 m. Data are presented as mean  SD from 14 -SYN-exposed and 13
control astrocytes and the levels of significance were set to *p  0.05, **p  0.01, and ***p  0.001 (D).
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Figure 6. Accumulation of -SYN oligomers results in mitochondrial defects and autophagy dysfunction. TEM analysis showed widespread mitochondrial fragmentation in -SYN oligomer-
exposed astrocytes compared with control cells (A) (white arrowheads indicate normal mitochondria and empty arrowheads indicate dense/fragmented mitochondria). Quantification of the
percentage of normal mitochondria versus dense/fragmented mitochondria using ImageJ demonstrated a significant increase of dense mitochondria in oligomer-exposed cultures (B). Immuno-
staining with COXIV antibody demonstrated increased formation of mitochondria aggregates (C and Fig. 6-1A, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f6-1, white arrow-
heads). The increased area of the mitochondria aggregates was confirmed by quantification using ImageJ analysis (D). Double staining with specific antibodies to COX IV and DRP-1 followed by
confocal imaging displayed an organized pattern of mitochondria and the fission-regulating protein DRP-1 3 d after -SYN oligomer exposure (24 h  3 d), preceding an excessive amount of
fragmented mitochondria at day 6 (24 h  6 d) (E and Fig. 6-1B, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f6-1). Close-ups of the white rectangles are shown in E. ATP
measurement showed only a very moderate decrease (7%) in ATP levels after -SYN oligomer treatment. In control cultures treated with the electron transport inhibitor antimycin A, there was also
a very low decrease in ATP levels (13%) compared with untreated cultures (F). Scale bars: A, 1 m; C, E, 20 m. Data are presented as mean  SD from 14 -SYN oligomer-exposed and 12 control
astrocytes (B) and as mean  SD from three independent experiments (D). The levels of significance were set to *p  0.05, **p  0.01, and ***p  0.001 (B, D).
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Figure 7. -SYN oligomer exposure affects the autophagosomal pathway. Immunostainings with specific antibodies to the autophagy marker LC3B showed an increased presence of LC3B
puncta after -SYN oligomer exposure (24 h  0 and 24 h  3 d) compared with untreated control cultures (A). Western blot analysis of LC3BI and II showed a significantly increased LC3BII/I ratio
(normalized to GAPDH) at 24 h  6 d when the cells were treated with the inhibitor bafilomycin A, suggesting a partial block of the autophagosomal machinery by the -SYN oligomers (B, C).
Western blot analysis of p62 showed a significant increased protein expression at day 6 after oligomer exposure (24 h  6 d) compared with untreated controls, (Figure legend continues.)
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going autophagy by visualizing fluorescently labeled LC3 puncta.
We could indeed identify the formation of LC3 puncta in
SYN-treated cultures (Fig. 7A). Interestingly, by day 6, the au-
tophagosomes were reduced to normal levels, indicating that the
autophagosomal pathway was initially induced but then halted,
although the fragmented mitochondria were still present (Fig.
7A). To investigate whether -SYN oligomer exposure affects
autolysosomal formation and degradation, cells were exposed to
bafilomycin A, which inhibits the formation of the autolysosome
and neutralizes the lysosomal pH, leading to less degradation.
This treatment will then cause accumulation of the LC3II and p62
proteins because the proteins will not be degraded by the autoly-
sosomes. Interestingly, the -SYN and bafilomycin-treated cells
showed a significantly higher LC3II/I ratio compared with cul-
tures treated with bafilomycin only. These data demonstrate that
the SYN oligomers interfere with the autophagosome/lysosome
fusion and partially block the autophagic flux (Klionsky et al.,
2016; Fig. 7B,C). Furthermore, Western blot analysis showed a
significant increase in the expression of p62 in astrocyte cultures
at day 6 after SYN oligomer exposure, indicating that the SYN
oligomers interfere with the autophagosome/lysosome fusion,
which is in consistent with the LC3II results (Fig. 7C,D). Using an
autophagy tandem sensor RFP-GFP kit, we transfected the astro-
cytes with plasmids containing the LC3B gene coupled to RFP-
and pH-sensitive GFP. This technique makes it possible to follow
the turnover of autophagosomes to autolysosomes because the
GFP protein is degraded when it comes into contact with low pH.
Interestingly, we found a significantly higher number of astro-
cytes with RFP but GFP vesicles at day 3 after SYN oligomer
exposure, demonstrating that there is an upregulation of autoly-
sosome formation at this time point. However, at day 6 after
SYN oligomer exposure, the number of astrocytes with RFP
GFP vesicles were similar to control cultures (Fig. 7F–H and
Fig. 7–1, available at https://doi.org/10.1523/JNEUROSCI.
1005-17.2017.f7-1). Together, these results suggest that the
-SYN oligomer exposure induces activation of the autophago-
somal machinery, but that the autophagy is discontinued even
though the degradation is not completed.
Healthy astrocytes transmit mitochondria to stressed -SYN-
containing astrocytes
It was shown recently that mitochondria could transfer via TNTs
to rescue “injured” cells (Wang and Gerdes, 2015). Due to the
supporting nature of astrocytes in the brain, we wanted to test
whether this phenomenon also takes place in -SYN oligomer-
exposed human astrocytes. By labeling the mitochondria with
Mitotracker, we could identify transfer of mitochondria between
the astrocytes in -SYN-treated cultures (Fig. 8A). Next, we
sought to investigate whether healthy astrocytes could transfer
mitochondria to -SYN oligomer-exposed astrocytes. To this
end, we performed two different coculture experiments. In one
setup, RFP-expressing astrocytes (acceptor cells) were cocultured
with Mitotracker-labeled, -SYN oligomer-exposed astrocytes
(donor cells) (Fig. 8B). In the other setup, -SYN oligomer-
exposed astrocytes (acceptor cells) were cocultured with RFP-
expressing, Mitotracker-labeled astrocytes (donor cells) (Fig.
8C). Using this approach, we could clearly identify transfer of
Mitotracker-labeled mitochondria between the untreated and
the -SYN oligomer-exposed astrocytes via both direct transfer
(Fig. 8D) and TNTs (Fig. 8E). Quantification of the number of
acceptor cells in both experimental setups indicated that the
healthy astrocytes transferred significantly more mitochondria to
-SYN oligomer-exposed cells than the other way around (Fig.
8F, p  0.05). The addition of latrunculin B to the cocultures
resulted in a 2-fold decrease in the number of acceptor astrocytes
(Fig. 8G, p  0.001). In cocultures in which neither the acceptor cells
nor the donor cells were treated with -SYN oligomers, the level of
mitochondrial transfer was significantly lower than in -SYN
oligomer-exposed cultures (p  0.001) (Fig. 8-1, available at
https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f8-1).
Discussion
Compelling experimental data suggest that the transfer of toxic
-SYN species from affected cells to healthy cells results in the
anatomical spread of pathology seen during PD progression (Re-
casens and Dehay, 2014). However, the cell types responsible for
the -SYN propagation and the exact transmission mechanisms
remain to be elucidated. In a recent study, Abounit et al. (2016)
demonstrated that preformed -SYN fibrils could transfer be-
tween cultured mouse neurons via TNTs. However, no study has
yet demonstrated whether such transfer occurs directly between
bona fide human glia or human neurons and human glia. Here,
we report for the first time that aggregated -SYN can be trans-
ferred between human astrocytes via direct contact and newly
formed TNTs and that this transfer can be abrogated using the
pharmacological agent latrunculin B. Previous evidence for
TNTs in intercellular transfer of misfolded proteins comes pri-
marily from studies of prion diseases (Gousset et al., 2009). For
example, the prion protein (PrP) can spread from infected to
uninfected neurons or from dendritic cells to uninfected neurons
(Gousset et al., 2009). Interestingly, astrocytes that display early
PrP accumulation in affected brains have been shown to transfer
PrP effectively to uninfected neurons via cell-to-cell contact (Vic-
toria et al., 2016). In addition to PrP, TNT-mediated transfer of
A has been demonstrated to occur between primary rodent as-
trocytes (Wang et al., 2011).
Increasing evidence emphasizes that insufficient lysosomal
degradation is involved in the pathogenesis of different neurode-
generative diseases, including PD (Nixon, 2007; Nixon et al.,
2008; Appelqvist et al., 2013). Accordingly, it is known that pa-
tients with lysosomal storage disorders (LSDs) often develop
neurodegenerative diseases (Nixon, 2007; Appelqvist et al.,
2013). For LSDs such as multiple sulfatase deficiency and Gau-
cher disease, it has been shown that normal autophagic, endo-
cytic, and lysosomal vesicle trafficking can be essential for
preventing neurodegeneration (Mazzulli et al., 2011; Di Malta et
al., 2012). Here, we show that -SYN oligomers, after engulfment
by human astrocytes, colocalized with the endosomal–lysosomal
marker LAMP-1. However, although the intracellular deposits of
ingested -SYN oligomers persisted, the colocalization with
LAMP-1 declined drastically over time. In contrast to the oligom-
ers, -SYN monomers became fully degraded by the human as-
trocytes. These observations raised the question of whether the
oligomers affect the lysosomal machinery directly or if the -SYN
accumulation is due to an overall slow degradation of heavily
4
(Figure legend continued.) (n  3) (D, E). Next, astrocytes were transfected with plasmids
containing the LC3B gene coupled to RFP and pH-sensitive GFP. This autophagy tandem sensor
RFP–GFP technique makes it possible to follow the turnover of autophagosomes to autolyso-
somes because the GFP protein is degraded when it comes into contact with low pH. Represen-
tative images from the staining demonstrate that significantly more cells with RFP  but
GFP  autophagosomes were present at 24 h3 d compared with untreated control cultures
(F–H and Fig. 7-1, available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f7-1) Filled
arrowheads indicate RFP  GPP  vesicles and empty arrowheads indicate RFP  GPP  vesi-
cles. Scale bars: A, E, 20 m. Data are presented as mean  SD.
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Figure 8. Healthy astrocytes deliver mitochondria to -SYN oligomer-exposed astrocytes. Using Mitotracker transfection, we could demonstrate that mitochondria were present within TNTs
connecting the astrocytes (A). A close-up of the white rectangle is shown in A. Coculture experiments were performed using two different set-ups. Either, GFAP::tRFP astrocytes (red acceptor cells)
were cocultured with Mitotracker-transfected, -SYN oligomer-exposed astrocytes (donor cells) (B) or -SYN oligomer-exposed astrocytes (acceptor cells) were cocultured with GFAP::tRFP,
Mitotracker-transfected astrocytes (red donor cells) (C). Using immunocytochemistry, we identified transfer of mitochondria between the GFAP::tRFP astrocytes and the unlabeled astrocytes via
direct contact (dashed areas show the outline of separate cells) (D) and TNTs (E), a close-up of the white rectangle is shown in E. Quantification of the number of (Figure legend continues.)
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compacted material by the astrocytes. Our observations, together
with previous studies, indicate that it is probably a combination
of both.
We have demonstrated previously that astrocytes engulf large
amounts of aggregated A42 that are stored in the cells for a very
long time (Söllvander et al., 2016). Similarly, we have shown that
astrocytes effectively engulf dead cells both in vitro and in vivo and
they are degraded very slowly (Lööv et al., 2012). A general slow
digestion in astrocytes may be explained by their antigen presen-
4
(Figure legend continued.) Mitotracker  acceptor cells in the two coculture setups indicated that
the healthy astrocytes transferred significantly more mitochondria to -SYN oligomer-exposed cells
than the other way around (F). Addition of latrunculin B to the cocultures significantly decreased the
percentage of Mitotracker  acceptor cells (G). In addition, basal level of mitochondrial transfer was
investigated in untreated control cultures. Compared with -SYN oligomer-exposed cultures, the
number of Mitotracker  acceptor cells was significantly lower in the control cultures (see Fig. 8-1,
available at https://doi.org/10.1523/JNEUROSCI.0983-17.2017.f8-1). Scale bars: A, 20 m; D, E, 20
m. Data are presented as mean  SEM from three independent experiments and the levels of
significance were set to *p  0.05, **p  0.01, and ***p  0.001 (F, G).
Figure 9. Proposed model for the cellular effects of -SYN accumulation in astrocytes. Ingested -SYN oligomers are transported to early/late endsosomes (A), but the lysosomal degradation
is not completed (B). Instead, the aggregated -SYN is stored intracellularly in the TGN region (C). The -SYN accumulation is clearly stressful for the cell and results in swollen ER (D) and
mitochondria fragmentation (E). Impaired mitochondria are initially degraded by the autophagosomes (F). However, the mitophagy is insufficient and pathological mitochondria remain in the
astrocyte. Moreover, -SYN oligomer-exposed astrocytes rapidly deploy a “defense mechanism” that consists of sending out TNTs to other astrocytes, enabling direct intercellular transmission of
the toxic protein to healthy astrocytes (G). In return, healthy astrocytes send mitochondria to “rescue” stressed astrocytes (H).
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tation properties. Several studies have suggested that astrocytes
are involved in T-cell activation because they express major his-
tocompatibility complex class II (Cornet et al., 2000; Lööv et al.,
2015). Accordingly, T-cell infiltration has been observed in the
PD brain at advanced disease stages. Conversely, aggregated
-SYN has been shown to affect lysosomal function by inhibiting
the activity of lysosomal enzymes (Mazzulli et al., 2011). Interest-
ingly, lysosomal dysfunction in SH-SY5Y cells increases -SYN
release via exosomes (Alvarez-Erviti et al., 2011). Moreover, a
recent study demonstrated that lysosomes containing preformed
-SYN fibrils can transfer between neuronal cells (Abounit et al.,
2016). In this study, we did not observe any intercellular transfer
of -SYN situated within lysosomes, which could be explained by
the fact that astrocytes store the -SYN in LAMP-1 compart-
ments. The incomplete degradation of ingested -SYN oligomers
in human astrocytes leads to intracellular accumulation in the
TGN region. Retrograde transport of proteins from endosomes
to the TGN is a well known phenomenon (Bonifacino and Rojas,
2006). Localization of -SYN deposits in TGN has been demon-
strated previously to cause Golgi fragmentation, impaired vesic-
ular transport, blockage of ER–Golgi transport (Cooper et al.,
2006), and lysosomal dysfunction in dopaminergic neurons (Maz-
zulli et al., 2016). The -SYN oligomer-exposed human astrocytes
showed no signs of Golgi fragmentation or increased apoptosis,
but displayed severe ER swelling and autophagy disturbances, as
well as mitochondria impairment, indicating that the astrocytes
were substantially stressed.
There have been several hypotheses about how -SYN aggregates
induce mitochondrial dysfunction in neurons. Among these, distur-
bance of the mitochondria fission–fusion hemostasis, autopha-
gososme synthesis, and mitophagy function in particular has
been highlighted (Gui et al., 2012; Nakamura, 2013; Guardia-
Laguarta et al., 2014; Ryan et al., 2015). A functional autophago-
somal pathway is highly relevant to prevent neurodegeneration
because it is a key route for the degradation of a range of intracy-
toplasmic aggregate-prone proteins and is also a disposal route
for dysfunctional mitochondria. Our data demonstrate a wide-
spread mitochondrial fragmentation in the -SYN-treated astro-
cytes and suggest that the accumulation of -SYN aggregates in
the TGN region may disrupt the autophagosomal and mitophagy
machinery because the autophagosomal membranes are provided
by the ER and Golgi. Moreover, our examinations of various steps in
their autophagosomal pathway indicate that autophagy is induced
but then halted, although the fragmented mitochondria are still
present. These findings indicate that the accumulation of -SYN
in the astrocytes disrupts their lysosomal machinery and prevents
clearance of the damaged mitochondria. Consistent with our
findings, it has been shown previously that overexpression of
-SYN can inhibit autophagosome formation (Winslow et al.,
2010).
As a consequence of the ineffective degradation of -SYN
oligomers and mitochondrial disturbances, the stressed astro-
cytes deploy a “defense mechanism” that consists of sending out
TNTs to other astrocytes, enabling direct intercellular transfer of
the toxic protein to healthy astrocytes. In return, healthy astrocytes
send mitochondria to rescue the stressed, -SYN-accumulating as-
trocytes, suggesting that astrocytes naturally help each other by
compensating for protein aggregation and cellular stress with
new energy-producing mitochondria. This finding is consistent
with earlier observations that TNT-mediated transfer of mito-
chondria from healthy cells can rescue UV-treated cells from
apoptosis (Spees et al., 2006; Wang and Gerdes, 2015; Han et al.,
2016; Jiang et al., 2016). Moreover, it was shown recently that
mesenchymal stem cells can transfer their mitochondria to mac-
rophages via TNTs and thereby enhance macrophage phagocyto-
sis of bacteria (Jackson et al., 2016).
Neurodegenerative diseases, including PD, are defined by loss
of brain homeostasis (Giaume et al., 2007; Coulter and Eid, 2012;
Verkhratsky et al., 2012; Verkhratsky et al., 2013; Verkhratsky et
al., 2015), which could be explained, at least in part, by the fact
that severely stressed astrocytes are unable to fulfill their normal
tasks (Eroglu and Barres, 2010; Sofroniew and Vinters, 2010;
Verkhratsky et al., 2015). In conclusion, our data show that high
loads of -SYN in human astrocytes induced ER swelling, lyso-
somal–autophagosomal dysfunction, and consequently TNT-
mediated transfer of aggregated -SYN and mitochondria (Fig.
9). Using a pharmacological approach to inhibit TNT formation,
we abolished the transfer of both -SYN and mitochondria, iden-
tifying astrocytic TNTs as a possible drug target.
References
Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, Olivo-Marin JC,
Melki R, Zurzolo C (2016) Tunneling nanotubes spread fibrillar alpha-
synuclein by intercellular trafficking of lysosomes. EMBO J 35:2120 –
2138. CrossRef Medline
Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ,
Cooper JM (2011) Lysosomal dysfunction increases exosome-mediated
alpha-synuclein release and transmission. Neurobiol Dis 42:360 –367.
CrossRef Medline
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Uéda K, Ikeda K, Kuroda S (2003) Glial involvement in diffuse Lewy
body disease. Acta Neuropathol 105:163–169. Medline
Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo
T, Trojanowski JQ, Lee VM (1998) Glial cytoplasmic inclusions in white
matter oligodendrocytes of multiple system atrophy brains contain insol-
uble alpha-synuclein. Ann Neurol 44:415– 422. CrossRef Medline
Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D,
Rodriguez JJ, Nedergaard M (2012) Neurological diseases as primary
gliopathies: a reassessment of neurocentrism. ASN Neuro 4: pii: e00082.
CrossRef Medline
Verkhratsky A, Rodríguez JJ, Parpura V (2013) Astroglia in neurological
diseases. Future Neurol 8:149 –158. CrossRef Medline
Verkhratsky A, Nedergaard M, Hertz L (2015) Why are astrocytes impor-
tant? Neurochem Res 40:389 – 401. CrossRef Medline
Victoria GS, Arkhipenko A, Zhu S, Syan S, Zurzolo C (2016) Astrocyte-to-
neuron intercellular prion transfer is mediated by cell-cell contact. Sci
Rep 6:20762. CrossRef Medline
Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000)
NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and
oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99:14 –
20. CrossRef Medline
Wang X, Gerdes HH (2015) Transfer of mitochondria via tunneling nano-
tubes rescues apoptotic PC12 cells. Cell Death Differ 22:1181–1191.
CrossRef Medline
Wang X, Bukoreshtliev NV, Gerdes HH (2012) Developing neurons form
transient nanotubes facilitating electrical coupling and calcium signaling
with distant astrocytes. PLoS One 7:e47429. CrossRef Medline
Wang Y, Cui J, Sun X, Zhang Y (2011) Tunneling-nanotube development
in astrocytes depends on p53 activation. Cell Death Differ 18:732–742.
CrossRef Medline
Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C,
Loher T, Vilar M, Campioni S, Tzitzilonis C, Soragni A, Jessberger S, Mira
H, Consiglio A, Pham E, Masliah E, Gage FH, Riek R (2011) In vivo
demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad
Sci U S A 108:4194 – 4199. CrossRef Medline
Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE,
Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, Brown
S, O’Kane CJ, Rubinsztein DC (2010) alpha-Synuclein impairs mac-
roautophagy: implications for Parkinson’s disease. J Cell Biol 190:1023–
1037. CrossRef Medline
Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC (2005) Hydrogen per-
oxide alters membrane and cytoskeleton properties and increases in-
tercellular connections in astrocytes. J Cell Sci 118:3695–3703. CrossRef
Medline
Rostami et al. • Astrocytes Transfer Alpha-Synuclein via TNTs J. Neurosci., December 6, 2017 • 37(49):11835–11853 • 11853
